מונטהלוקאסט טבע ® 4 מ"ג

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

MONTELUKAST AS SODIUM 4 MG

Pieejams no:

TEVA PHARMACEUTICAL INDUST.LTD

ATĶ kods:

R03DC03

Zāļu forma:

CHEWABLE TABLETS

Ievadīšanas:

PER OS

Ražojis:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Ārstniecības grupa:

MONTELUKAST

Ārstēšanas norādes:

Montelukast Teva is indicated in pediatric patients 2 to 5 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. Montelukast Teva is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Montelukast Teva and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. Montelukast Teva is indicated for the relief of symptoms of seasonal allergic rhinitis in pediatric patients 2 to 5 years of age and older.

Autorizācija datums:

2010-06-01